A complete timeline of Ja Morant’s off-court controversies, from threatening a mall security guard to showing a gun on Instagram

Good Morning America

FDA approves first-of-its-kind drug to treat hot flashes

Women have suffered for centuries with hot flashes, one of the most common symptoms of menopause, without many treatment options. Now, the U.S. Food and Drug Administration has approved a first-of-its-kind drug, fezolinetant, sold under the brand name Veozah, to treat moderate to severe hot flashes during menopause. The drug, a pill taken once a day, is hormone-free, which makes it promising for women who cannot take hormone treatment because of other underlying health concerns, such as a prior history of strokes, heart attacks or blood clots.